Загрузка...
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020. Herculean efforts to rapidly design and produce vaccines and other antiviral intervent...
Сохранить в:
| Опубликовано в: : | J Lipid Res |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The American Society for Biochemistry and Molecular
Biology
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7328045/ https://ncbi.nlm.nih.gov/pubmed/32457038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.R120000851 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|